Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Update

Advanced Medical Isotope Corporation (OTCMKTS:RDGL – Get Free Report) was the target of a large increase in short interest in the month of September. As of September 15th, there was short interest totaling 33,174 shares, an increase of 219.3% from the August 31st total of 10,391 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 1,979,498 shares, the days-to-cover ratio is presently 0.0 days.

Advanced Medical Isotope Trading Down 1.7%

OTCMKTS RDGL traded down $0.00 during trading on Friday, hitting $0.05. The company had a trading volume of 203,783 shares, compared to its average volume of 778,150. The company’s fifty day moving average is $0.05 and its 200-day moving average is $0.07. Advanced Medical Isotope has a one year low of $0.04 and a one year high of $0.12. The company has a market cap of $22.67 million, a price-to-earnings ratio of -4.59 and a beta of -0.72.

About Advanced Medical Isotope

(Get Free Report)

Advanced Medical Isotope Corporation is a medical technology company developing targeted radiation products for cancer treatment. Its primary product candidate is RadioGelâ„¢, an injectable brachytherapy device designed to deliver yttrium-90 radiation directly to solid tumors. The company’s approach is intended to provide localized treatment while limiting radiation exposure to surrounding healthy tissue.

RadioGel is being developed for potential use in treating tumors that may be difficult to address with conventional external-beam radiation or surgery.

Further Reading

Receive News & Ratings for Advanced Medical Isotope Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Isotope and related companies with MarketBeat.com's FREE daily email newsletter.